IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 325 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,716,378 | +16.3% | 192,160 | +5.2% | 0.00% | +50.0% |
| Q2 2023 | $7,496,755 | -52.6% | 182,714 | -58.7% | 0.00% | -60.0% |
| Q1 2023 | $15,826,169 | +91312.1% | 442,885 | -3.4% | 0.01% | 0.0% |
| Q4 2022 | $17,313 | -99.9% | 458,444 | -18.3% | 0.01% | -50.0% |
| Q3 2022 | $24,810,000 | +14.6% | 560,928 | -4.1% | 0.01% | +25.0% |
| Q2 2022 | $21,658,000 | +65.5% | 585,048 | +65.5% | 0.01% | +100.0% |
| Q1 2022 | $13,089,000 | +11.2% | 353,481 | -8.6% | 0.00% | 0.0% |
| Q4 2021 | $11,767,000 | -1.4% | 386,691 | +8.7% | 0.00% | 0.0% |
| Q3 2021 | $11,935,000 | -27.1% | 355,839 | -13.3% | 0.00% | -20.0% |
| Q2 2021 | $16,362,000 | -20.4% | 410,217 | -10.3% | 0.01% | -28.6% |
| Q1 2021 | $20,563,000 | -19.0% | 457,281 | +1.8% | 0.01% | -22.2% |
| Q4 2020 | $25,396,000 | +18.6% | 449,104 | -0.5% | 0.01% | 0.0% |
| Q3 2020 | $21,420,000 | -13.3% | 451,318 | +7.7% | 0.01% | -18.2% |
| Q2 2020 | $24,710,000 | +49.9% | 419,071 | +20.2% | 0.01% | +22.2% |
| Q1 2020 | $16,482,000 | -10.1% | 348,572 | +14.8% | 0.01% | +28.6% |
| Q4 2019 | $18,336,000 | +9.0% | 303,529 | +8.1% | 0.01% | 0.0% |
| Q3 2019 | $16,820,000 | -4.3% | 280,785 | +2.7% | 0.01% | 0.0% |
| Q2 2019 | $17,570,000 | -28.9% | 273,351 | -10.3% | 0.01% | -30.0% |
| Q1 2019 | $24,720,000 | +56.2% | 304,577 | +4.0% | 0.01% | +42.9% |
| Q4 2018 | $15,827,000 | +14.2% | 292,868 | +9.0% | 0.01% | +40.0% |
| Q3 2018 | $13,860,000 | +40.0% | 268,699 | +13.1% | 0.01% | +25.0% |
| Q2 2018 | $9,902,000 | -5.5% | 237,618 | +0.0% | 0.00% | 0.0% |
| Q1 2018 | $10,473,000 | -7.4% | 237,581 | +5.7% | 0.00% | -20.0% |
| Q4 2017 | $11,309,000 | +9.3% | 224,811 | +10.2% | 0.01% | 0.0% |
| Q3 2017 | $10,347,000 | +3.3% | 204,022 | +3.7% | 0.01% | 0.0% |
| Q2 2017 | $10,014,000 | +46.3% | 196,812 | +15.6% | 0.01% | +66.7% |
| Q1 2017 | $6,847,000 | +47.1% | 170,316 | +75.0% | 0.00% | +50.0% |
| Q4 2016 | $4,656,000 | +503.1% | 97,341 | +361.7% | 0.00% | – |
| Q3 2016 | $772,000 | +180.7% | 21,082 | +78.4% | 0.00% | – |
| Q2 2016 | $275,000 | -93.9% | 11,814 | -89.4% | 0.00% | -100.0% |
| Q1 2016 | $4,510,000 | -25.1% | 111,407 | +14.6% | 0.00% | -25.0% |
| Q4 2015 | $6,020,000 | – | 97,216 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |